| Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders P Robert, CU Onyike, AFG Leentjens, K Dujardin, P Aalten, S Starkstein, ... European Psychiatry 24 (2), 98-104, 2009 | 760 | 2009 |
| Treatment of schizophrenia with long-acting injectable risperidone: a 12-month open-label trial of the first long-acting second-generation antipsychotic WW Fleischhacker, M Eerdekens, K Karcher, G Remington, PM Llorca, ... Journal of Clinical Psychiatry 64 (10), 1250-1257, 2003 | 415 | 2003 |
| Assessment and management of agitation in psychiatry: expert consensus M Garriga, I Pacchiarotti, S Kasper, SL Zeller, MH Allen, G Vazquez, ... The world journal of biological psychiatry 17 (2), 86-128, 2016 | 389 | 2016 |
| Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review A Chevance, D Gourion, N Hoertel, PM Llorca, P Thomas, R Bocher, ... L'encephale 46 (3), 193-201, 2020 | 353 | 2020 |
| Treated incidence of psychotic disorders in the multinational EU-GEI study HE Jongsma, C Gayer-Anderson, A Lasalvia, D Quattrone, A Mulè, ... JAMA psychiatry 75 (1), 36-46, 2018 | 326 | 2018 |
| Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations European Network of National Networks studying Gene-Environment Interactions ... Schizophrenia bulletin 40 (4), 729-736, 2014 | 281 | 2014 |
| Diagnostic criteria for apathy in clinical practice E Mulin, E Leone, K Dujardin, M Delliaux, A Leentjens, F Nobili, B Dessi, ... International journal of geriatric psychiatry 26 (2), 158-165, 2011 | 278 | 2011 |
| COVID-19 pandemic lockdown and problematic eating behaviors in a student population V Flaudias, S Iceta, O Zerhouni, RF Rodgers, J Billieux, PM Llorca, ... Journal of behavioral addictions 9 (3), 826-835, 2020 | 244 | 2020 |
| Association between mental health disorders and mortality among patients with COVID-19 in 7 countries: a systematic review and meta-analysis G Fond, K Nemani, D Etchecopar-Etchart, A Loundou, DC Goff, SW Lee, ... JAMA psychiatry 78 (11), 1208-1217, 2021 | 238 | 2021 |
| Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness PM Llorca, M Abbar, P Courtet, S Guillaume, S Lancrenon, L Samalin BMC psychiatry 13, 1-17, 2013 | 234 | 2013 |
| Partial compliance in schizophrenia and the impact on patient outcomes PM Llorca Psychiatry research 161 (2), 235-247, 2008 | 229 | 2008 |
| Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia P Damier, S Thobois, T Witjas, E Cuny, P Derost, S Raoul, P Mertens, ... Archives of general psychiatry 64 (2), 170-176, 2007 | 225 | 2007 |
| Compliance in schizophrenia: predictive factors, therapeutical considerations and research implications D Misdrahi, PM Llorca, C Lancon, FJ Bayle L'encephale 28 (3 Pt 1), 266-272, 2002 | 214* | 2002 |
| Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? PP Derost, L Ouchchane, D Morand, M Ulla, PM Llorca, M Barget, ... Neurology 68 (17), 1345-1355, 2007 | 206 | 2007 |
| Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study PM Llorca, C Spadone, O Sol, A Danniau, T Bougerol, E Corruble, ... Journal of Clinical Psychiatry 63 (11), 1020-1027, 2002 | 193 | 2002 |
| Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies HJ Möller, PM Llorca, E Sacchetti, SD Martin, R Medori, E Parellada, ... International Clinical Psychopharmacology 20 (3), 121-130, 2005 | 189 | 2005 |
| Risk factors for treatment resistance in unipolar depression: a systematic review D Bennabi, B Aouizerate, W El-Hage, O Doumy, F Moliere, P Courtet, ... Journal of affective disorders 171, 137-141, 2015 | 179 | 2015 |
| Psychopathological features of a patient population of targets of workplace bullying G Brousse, L Fontana, L Ouchchane, C Boisson, L Gerbaud, D Bourguet, ... Occupational medicine 58 (2), 122-128, 2008 | 177 | 2008 |
| The “Functional Remission of General Schizophrenia”(FROGS) scale: development and validation of a new questionnaire PM Llorca, C Lançon, S Lancrenon, FJ Bayle, H Caci, F Rouillon, ... Schizophrenia research 113 (2-3), 218-225, 2009 | 167 | 2009 |
| Assessment of hyper-and hypodopaminergic behaviors in Parkinson's disease C Ardouin, I Chéreau, PM Llorca, E Lhommée, F Durif, P Pollak, P Krack Revue neurologique 165 (11), 845-856, 2009 | 153* | 2009 |
Ludovic SAMALINCHU Clermont-Ferrand - University of AuvergnePreverjeni e-poštni naslov na chu-clermontferrand.fr
